Pulmonary resection in metastatic carcinoma.
Resection of pulmonary metastases in osteogenic sarcoma has been reported by us to result in a five-year survival rate of 27 percent. A later report of surgical management of pulmonary metastases from all types of sarcomas showed a five-year survival rate of 26%. This report reviews the experience with 188 patients treated surgically for pulmonary metastasis from a variety of carcinomas, demonstrating that a similar rate of survival is obtainable by surgical excision of these metastases. A total of 188 patients underwent 242 thoractomies for metastatic pulmonary carcinomas. The most frequent sites of origin were the colon, melanoma, breast, and testicular carcinoma. Surgical treatment of these metastases is justified when the following criteria are adhered to: (1) primary site controlled or controllable; (2) no extrapulmonary metastatic sites demonstrable; (3) good surgical risk; and (4) no effective treatment available by nonsurgical means.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003110:Colonic Neoplasms / Q000150:complications; D005260:Female; D006258:Head and Neck Neoplasms / Q000150:complications; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000150:complications; D008175:Lung Neoplasms / Q000209:etiology / Q000401:mortality* / Q000601:surgery*; D008297:Male; D008545:Melanoma / Q000601:surgery; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012004:Rectal Neoplasms / Q000150:complications; D013736:Testicular Neoplasms / Q000150:complications; D001749:Urinary Bladder Neoplasms / Q000150:complications